Trial
NCT05067517
Efficacy & Safety of Nintedanib in Patients With Progressive Fibrosing Coal Mine Dust-Induced Interstitial Lung Disease
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
West Virginia University
Collaborators
—
Condition
Progressive Fibrosing Interstitial Lung Disease
Intervention
Nintedanib
Why stopped
Unable to enroll any subjects. IRB closed study in agreement with PI.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-24